XML 17 R7.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Operating activities        
Net earnings (loss) $ (8,912) $ (3,126) $ 16,683 $ (7,588)
Items not affecting cash:        
Depreciation and amortization 8,186 8,189 16,488 16,330
Amortization of debt issuance costs 684 600 1,339 1,208
Deferred income taxes (2,356) (865) 4,971 (2,151)
Stock-based compensation 2,998 2,104 2,835 4,275
Unrealized gain on derivative contracts (400) (2,764) (288) (1,243)
Loss (gain) on sale of business 201 0 (45,378) 0
Fair value of contingent consideration   43   (2,373)
Impairment of long-lived assets   70   409
Other (72) (148) (134) (147)
Changes in non-cash working capital, net of businesses acquired or sold (31,989) (38,324) (27,188) (35,435)
Net cash flows from operations (31,660) (34,221) (30,672) (26,715)
Investing activities        
Net proceeds from sale of business (201)   64,675  
Purchases of property, plant and equipment (9,341) (10,428) (17,315) (17,163)
Acquisition of business, net of cash acquired (3,341)   (3,341)  
Proceeds from sale of assets   30   730
Other   389   389
Net cash flows from investing activities (12,883) (10,009) 44,019 (16,044)
Financing activities        
Increase (decrease) under line of credit facilities 43,367 49,885 (11,294) 50,194
Borrowings under long-term debt 24   1,876  
Repayment of long-term debt (634) (415) (1,357) (937)
Payment of cash dividends on Series A Preferred Stock (1,700) (1,700) (3,400) (3,400)
Proceeds from the exercise of stock options and employee share purchases 37 91 265 240
Payment of debt issuance costs (81)   (395)  
Payment of contingent consideration   (4,399)   (4,399)
Other (5) (5) 216 (45)
Net cash flows from financing activities 41,008 43,457 (14,089) 41,653
Foreign exchange gain (loss) on cash held in a foreign currency 50 (64) (8) (35)
Decrease in cash and cash equivalents in the period (3,485) (837) (750) (1,141)
Cash and cash equivalents - beginning of the period 6,015 2,924 3,280 3,228
Cash and cash equivalents - end of the period 2,530 2,087 2,530 2,087
Non-cash financing activity        
Accrued cash dividends on Series A Preferred Stock $ (1,700) $ (1,700) $ (1,700) $ (1,700)